With more and more research and clinical data testing, MIF shows great potential in AKI being an independent predictive factor and is more advantageous than existing biomarkers owing to the fact that the source of MIF is from the kidney itself, acting pleiotropic and reacting to injuries quickly, which meets the criteria as a biological marker of AKI. Here, MIF is linked to acute kidney injury.